Filing Flows › Selectis Health (GBCS) › Q4 2024
Selectis Health (GBCS) Q4 2024 earnings results (fourth quarter 2024)
10-K filed Apr 15, 2025
Selectis Health (GBCS) reported revenue of $10.4M for the fourth quarter 2024 (Q4 2024), +13% from a year earlier and +4% from the quarter before. Operating margin was -0.9%, net loss $576K (5.5% of revenue).
Selectis Health, Q4 2024: revenue $10.4M (+13% year over year), operating margin -0.9%, net loss $576K, operating cash flow −$423K. The chart follows the revenue to costs, profit and cash.
| Q4 2024 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $10.4M | +4% | +13% |
| Operating profit | −$97K | — | — |
| Net earnings | −$576K | — | — |
| Operating cash flow | −$423K | — | — |
What changed
Revenue was $10.4M in Q4 2024, up 13% year over year and up 4% from the previous quarter.
Operating costs exceeded revenue by $97K, an operating margin of -0.9%. Total costs fell 14% while revenue rose 13%. The quarter ended with a net loss of $576K, narrower than the previous quarter's $1.6M loss. Net interest and other expense of $479K was the main reason.
Operating cash flow was −$423K. Non-cash charges added back $363K of depreciation and amortization. Working capital and other items used $210K. Capital expenditures of $10K exceeded it, leaving free cash flow of −$433K.
Questions
What was Selectis Health's revenue in the fourth quarter 2024?
Selectis Health (GBCS) reported revenue of $10.4M for the fourth quarter 2024 (Q4 2024), +13% from a year earlier and +4% from the quarter before.
Was Selectis Health profitable in the fourth quarter 2024?
Operating loss was $97K (-0.9% of revenue) and net loss $576K.
Source: Selectis Health 10-K on SEC EDGAR.